Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

The knockoff surge was led by Hims & Hers Health, the telehealth firm that began selling the drugs last spring.

Lauritz Knudsen Electrical and Automation (formerly L & T Switchgear), a leader in the Indian electrical and automation ...

Persistent's Santosh Dixit and Google's Shweta Maniar discuss their joint solution, Pi-OmniKG, and its impact on the life ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Daymond John from "Shark Tank" made a surprise appearance at a major health tech conference—and remarked on the number of exhibitors.

Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...

We list the best open source software, to make it simple and easy to do everyday tasks without having to pay for software licenses. Open source software is any kind of program that anyone in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase, and achieved $126 million in GAAP net income. The company’s subscriber base reached 2.2 million ...